Related Experiment Video
Updated: Jul 28, 2025
09:47
Isolation, Processing and Analysis of Murine Gingival Cells
Published on: July 2, 2013
19.1K
Free sugars and gingival inflammation: A systematic review and meta-analysis
J P Woelber1, D Gebhardt1, P P Hujoel2,3
1Department of Operative Dentistry and Periodontology, Faculty of Medicine, University of Freiburg, Freiburg, Germany.
Journal of Clinical Periodontology
|May 29, 2023
Summary
Reducing free sugar intake significantly improves gingival health and reduces inflammation. This systematic review highlights the benefits of dietary changes for oral health.
Area of Science:
- Oral Health & Periodontology
- Dietary Science
- Public Health
Background:
- High consumption of free sugars is linked to chronic diseases.
- Gingival inflammation is a prevalent oral health issue.
- Understanding the impact of free sugars on gingival health is crucial for preventive strategies.
Approach:
- Conducted a systematic review and meta-analysis adhering to the Cochrane Handbook.
- Included controlled clinical studies investigating free-sugar interventions and gingival inflammation.
- Assessed risk of bias using ROBINS-I and ROB-2, and estimated effect sizes with robust variance meta-regressions.
Key Points:
- Analyzed 9 studies with 209 participants, finding statistically significant improvements in gingival health scores with free sugar restriction (SMD = -0.92).
- Observed a trend towards lower dental plaque scores (SMD = -0.61) with reduced free sugar intake.
- Results were robust against statistical imputations, indicating reliability.
Conclusions:
- Restriction of free sugar consumption is associated with reduced gingival inflammation.
- Dietary modifications, specifically limiting free sugars, can positively impact oral health outcomes.
- Further research may be needed due to the limited number of studies and moderate risk of bias observed.
Related Concept Videos
01:19Oral Hypoglycemic Agents: α-Glucosidase Inhibitors
220
α-glucosidase inhibitors, including acarbose (Precose), miglitol (Glyset), and voglibose (Voglib) (primarily available in Asia), are drugs that control blood sugar levels by delaying the digestion of starch and disaccharides. They achieve this by inhibiting α-glucosidase enzymes in the intestine, which slow the absorption of carbohydrates in the intestine, which in turn leads to a prolonged release of the glucoregulatory hormone GLP-1 from intestinal L-cells.
Acarbose and miglitol are...
Acarbose and miglitol are...
220
01:26Oral Hypoglycemic Agents: Biguanides and Glitazones
241
Biguanides, particularly metformin (Glucophage), are insulin sensitizers that enhance glucose uptake, thereby reducing insulin resistance. Unlike sulfonylureas, metformin doesn't prompt insulin secretion, which helps to curb hypoglycemia risk. Metformin is beneficial in treating conditions like polycystic ovary syndrome due to its insulin-resistance reduction capability. The drug's primary action involves curtailing hepatic gluconeogenesis, a significant contributor to high blood...
241
01:06Oral Hypoglycemic Agents: Glinides
190
Repaglinide (Prandin) and Nateglinide (Starlix), known as glinides, are oral insulin secretagogues that stimulate insulin release from pancreatic β cells by closing the ATP-sensitive potassium channels (KATP channel). Repaglinide controls insulin release from pancreatic β cells by managing potassium efflux. It shares two binding sites with sulfonylureas and also has a unique site, indicating overlapping mechanisms of action. With a rapid onset and a 4-7 hour duration, it effectively...
190
01:27Glucose Transporters
23.6K
Glucose transporters facilitate the transport of glucose across the cell membrane. In addition to glucose, some glucose transporters can also aid the movement of other hexoses such as fructose, mannose, and galactose.
Facilitated diffusion-glucose transporters (GLUTs) are encoded by the solute-linked carrier (SLC) family 2, subfamily A gene family, or SLC2A. The 14 GLUT protein members are distributed into three classes:
Facilitated diffusion-glucose transporters (GLUTs) are encoded by the solute-linked carrier (SLC) family 2, subfamily A gene family, or SLC2A. The 14 GLUT protein members are distributed into three classes:
23.6K
01:17Oral Hypoglycemic Agents: Sulfonylureas
251
Sulfonylureas are oral hypoglycemic agents utilized in treating type 2 diabetes. They are characterized by their unique sulfonylurea chemical structure. The family of sulfonylureas is divided into generations. First-generation sulfonylureas, including tolbutamide (Orinase), chlorpropamide (Diabinese), and tolazamide (Tolinase), trigger insulin release from pancreatic β cells and enhance peripheral tissues' insulin sensitivity. The second-generation members, such as glipizide...
251